3UC-32230-22466
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 481 / MI
- Registered
- 2022-06-09
- Relationship
- Child or adolescent in my care
- Guardian
- V8T-22285-07390
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-05-28
Dose 1 — Pfizer-BioNTech
-
2022-06-09
Registered in v-safe
- 2022-06-09
- 2022-06-11
- 2022-06-18
-
2022-06-24
Dose 2 — Pfizer-BioNTech
-
2022-06-25
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Injection site bruising — Feeling: Fair · Site: SwellingFree text: Bruise at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-03
- 2022-07-10
- 2022-07-15
- 2022-07-22
-
2022-07-29
Survey response — day 35, dose 2, dependentMedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Report sent to call center — day 35, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-05-28 | Pfizer-BioNTech | No |
| 2 | 2022-06-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-29 | Successful 2022-08-01 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Bruise at injection site
Release 12 — day 35, dose 2, dependent
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release